Sukhjit Starch & Chemicals per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
₹14.45₹5.65₹12.79₹31.98₹40.56
₹14.45₹8.65₹12.79₹31.98₹40.56
₹181.61₹181.61₹173.84₹321.79₹298.03
₹496.93₹458.52₹479.50₹880.51₹926.10
—₹1.22₹21.69₹49.77₹26.24
−₹3.62−₹3.62₹8.94₹22.53₹2.64
—₹1.06₹0.04₹7.87₹8.05
3.13.13.11.61.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SUKHJITS₹142.37

Sukhjit Starch & Chemicals Limited

· FMCG & Retail
₹ CrorePeersSARVESHWARNATHBIOGENREGAALBSHSLINDOUSGULPOLYKOHINOORAVTNPLMcap ₹445 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS40.5631.9812.795.6514.45
Diluted EPS40.5631.9812.798.6514.45
Book Value per Share298.03321.79173.84181.61181.61
Revenue per Share926.10880.51479.50458.52496.93
Cash Flow per Share26.2449.7721.691.22—
Free Cash Flow per Share2.6422.538.94-3.62-3.62
Dividends per Share8.057.870.041.06—
Shares Outstanding (cr)1.61.63.13.13.1
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.